FibroGen (FGEN)

FibroGen (FGEN) Financial Statements


FibroGen Financial Overview

FibroGen's market cap is currently ―. The company's EPS TTM is $-3.058; its P/E ratio is -0.62; FibroGen is scheduled to report earnings on February 26, 2024, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 40.13M$ 23.89M$ 24.16M$ 34.37M$ 15.73M
Gross Profit$ 35.89M$ 44.32M$ 32.67M$ 29.44M$ 11.43M
EBIT$ -59.19M$ -79.69M$ -75.06M$ -72.83M$ -91.86M
EBITDA$ -58.65M$ -78.10M$ -72.78M$ -70.38M$ -89.18M
Net Income Common Stockholders$ -67.91M$ -87.68M$ -77.74M$ -59.50M$ -91.65M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 251.34M$ 335.72M$ 355.95M$ 422.01M$ 408.52M
Total Assets$ 460.43M$ 515.13M$ 538.54M$ 610.09M$ 608.84M
Total Debt$ 153.59M$ 156.23M$ 86.81M$ 89.89M$ 92.59M
Net Debt$ -97.75M$ -179.48M$ -269.14M$ -332.12M$ -315.93M
Total Liabilities$ 575.63M$ 575.43M$ 567.43M$ 611.57M$ 562.56M
Stockholders Equity$ -157.17M$ -102.27M$ -48.85M$ -21.45M$ 26.31M
Cash Flow-
Free Cash Flow$ -85.22M$ -111.56M$ -102.18M$ -52.85M$ -52.74M
Operating Cash Flow$ -84.54M$ -110.57M$ -101.59M$ -52.51M$ -51.88M
Investing Cash Flow$ 54.22M$ -14.29M$ 103.48M$ 1.09M$ 44.78M
Financing Cash Flow$ -22.00K$ 91.53M$ 31.48M$ 48.67M$ -1.09M
Currency in USD

FibroGen Earnings and Revenue History

FibroGen Debt to Assets

FibroGen Cash Flow

FibroGen Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis